Browsing Caprisa (Centre for the Aids programme of research in South Africa) by Title
Now showing items 353-372 of 447
-
A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.
(American Society for Microbiology., 2005)In human immunodeficiency virus type 1 (HIV-1) subtype B infections, the emergence of viruses able to use CXCR4 as a coreceptor is well documented and associated with accelerated CD4 decline and disease progression. However, ... -
Replication capacity of viruses from acute infection drives HIV-1 disease progression.
(American Society for Microbiology., 2017)Abstract available in pdf. -
Research ethics governance in times of Ebola.
(Oxford University Press., 2017)Abstract available in pdf. -
Restoration of CD4+ responses to copathogens in HIV-infected individuals on antiretroviral therapy is dependent on T cell memory phenotype.
(American Association of Immunologists., 2015)Abstract available in pdf. -
Results from the workshop “problem formulation for the use of gene drive in mosquitoes”.
(American Society of Tropical Medicine and Hygiene., 2017)Abstract available in pdf. -
Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials.
(Future Medicine., 2010)No abstract available. -
A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection.
(Springer., 2018)Abstract available in pdf. -
A review of progress on HIV, AIDS and Tuberculosis.
(2010)As a United Nations member state, South Africa is signatory to the Millennium Declaration and is committed to achieve the Millennium Development Goals (MDGs) and targets for 2015. This chapter provides an overview ... -
Rifampicin mono-resistance in mycobacterium tuberculosis in KwaZulu-Natal, South Africa : A significant phenomenon in a high prevalence TB-HIV region.
(PLoS One, 2013)Setting: The dual epidemics of HIV-TB including MDR-TB are major contributors to high morbidity and mortality rates in South Africa. Rifampicin (RIF) resistance is regarded as a proxy for MDR-TB. Currently available ... -
Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.
(AIDS, 2017)Abstract available in pdf. -
Risk factors for HIV acquisition in high risk women in a generalised epidemic setting.
(Springer., 2015)Abstract available in pdf. -
Risk factors for incidence of sexually transmitted infections among women in a human immunodeficiency virus chemoprevention trial : VOICE (MTN-003).
(American Sexually Transmitted Diseases Association., 2017)Abstract available in pdf. -
Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study.
(Elsevier., 2015)Abstract available -
Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis–HIV-co-infected patients in resource-constrained settings.
(Lippincott Williams & Wilkins., 2005)No abstract available. -
Robust inference of positive selection from recombining coding sequences.
(Oxford University Press., 2006)Motivation: Accurate detection of positive Darwinian selection can provide important insights to researchers investigating the evolution of pathogens. However, many pathogens (particularly viruses) undergo frequent ... -
The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: Are there opportunities to intervene?
(Sage Publications., 2015)Abstract available in pdf. -
Role of education in HIV clinical outcomes in a tuberculosis endemic setting.
(Sage., 2013)This study evaluated how educational attainment impacts clinical outcomes of HIV-positive patients in Durban, South Africa. The authors conducted a prospective study of 466 adult HIV-positive patients initiating antiretroviral ... -
Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.
(The Union., 2014)Abstract available in pdf. -
Routine feedback of test results to participants in clinic-and survey-based surveillance of HIV.
(World Health Organization., 2015)Abstract available in pdf. -
Safety and effectiveness of BufferGel and 0.5% PRO 2000 gel for the prevention of HIV infection in women.
(Lippincott Williams & Wilkins., 2010)Objective: To determine the safety and effectiveness of BufferGel and 0.5% PRO2000 microbicide gels for the prevention of male-to-female HIV transmission. Design: Phase II/IIb, randomized, placebo-controlled trial with ...